Ads
related to: global pharma- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Solvent Center
Our Solvents include HPLC, ACS,
Anhydrous, Reagent Grade and more
- Stockroom Reagents
Solvents, Acids/Bases, Absorbents,
Filter Aids, Drying Agents and more
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Lab Products & Equipment
Search results
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Digital Journal· 14 hours agoAlgernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 18 hours agoToday Axiom announced that its on-demand legal talent network has surpassed 200 lawyers with specific AI experience, giving in-house corporate legal teams and businesses of all sizes immediate ...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks· 6 days agoPharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH Quick QuoteXPH - Free Report) is a passively managed exchange traded fund launched on 06/19/2006 ...
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Digital Journal· 12 hours agoVienna ball season back in...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 5 days agoCollaborations and agreements continue to be in the spotlight aspharma and biotech majors look to...
AstraZeneca aims for $80 billion in total revenue by 2030
Reuters via Yahoo News· 19 hours agoAstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by...
The 3 Most Undervalued Penny Stocks to Buy in May 2024
InvestorPlace· 4 days agoPenny stocks are a horrible investment. Selling for less than $1 per share, penny stocks are cheap...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 11 hours agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves. AstraZeneca announced ...
Deal Watch: Big Week in Deals as Creative Dealmaking Merges With More Activity | The American Lawyer
Law.com· 1 day agoIt was another strong past week in merger and acquisition deals, with at least eight announced...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...